Resverlogix超額完成BETonMACE第3階段關鍵臨床試驗的患者招募
March 20, 2018 01:20 ET
|
Resverlogix Corp
阿爾伯塔省卡爾加里, March 20, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp.（下文稱為「Resverlogix」或「公司」）(TSX:RVX)...
Resverlogix超额实现BETonMACE关键第3阶段临床试验的患者招募
March 20, 2018 01:20 ET
|
Resverlogix Corp
阿尔伯塔省卡尔加里, March 20, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp.（“Resverlogix”或“公司”）(TSX:RVX) 今天宣布，公司在进行中的BETonMACE第3阶段试验已经成功超额实现招募2,400名患者的计划目标，其中首例患者于2015年11月11日招募。这一试验的目标是确认Resverlogix...
Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial
March 19, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, March 19, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has successfully surpassed the planned enrollment target of...
Resverlogix Announces Sixth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
February 26, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announced that the independent Data and Safety Monitoring Board (DSMB) for the...
Resverlogix Highlights Key Accomplishments and 2018 Targets
February 08, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) highlighted today recent key accomplishments and 2018 targets. Recent...
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
January 11, 2018 09:33 ET
|
Resverlogix Corp
CALGARY, Alberta, Jan. 11, 2018 (GLOBE NEWSWIRE) --
Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) and the Resverlogix BETonMACE Clinical Steering Committee (CSC),...
Resverlogix 和 Medison Pharma Ltd. 公佈戰略授權合約
January 09, 2018 08:32 ET
|
Resverlogix Corp
阿爾伯塔省卡爾加里, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp.（下文稱為「 Resverlogix 」或「公司」）(TSX:RVX) 今日宣佈，已經與 Medison Pharma Ltd.（下文稱為「 Medison 」）簽訂授權合約，力促公司的主要治療候選藥物 Apabetalone (RVX-208)...
Resverlogix 和 Medison Pharma Ltd. 公布战略许可协议
January 09, 2018 08:32 ET
|
Resverlogix Corp
阿尔伯塔省卡尔加里, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp.（下称“Resverlogix”或“公司”）(TSX:RVX) 今日宣布，已经与 Medison Pharma Ltd.（下称“Medison”）签订许可协议，力促公司的主要治疗候选药物 Apabetalone (RVX-208)...
Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement
January 08, 2018 08:57 ET
|
Resverlogix Corp
CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that it has entered into a licensing agreement with Medison...
Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis
December 14, 2017 19:27 ET
|
Resverlogix Corp
CALGARY, Alberta, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announced today that it has filed its unaudited interim Consolidated Financial...